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Abstract
Olfactory systems utilize discrete neural pathways to process and integrate odorant information. In
Drosophila, axons of first-order olfactory receptor neurons (ORNs) and dendrites of second-order
projection neurons (PNs) form class-specific synaptic connections at ∼50 glomeruli. The
mechanisms underlying PN dendrite targeting to distinct glomeruli in a 3-dimensional discrete
neural map are unclear. Here we show that the leucine-rich repeat (LRR) transmembrane protein
Capricious (Caps) is differentially expressed in different classes of PNs. Loss- and gain-of-
function studies indicate that Caps instructs the segregation of Caps-positive and negative PN
dendrites to discrete glomerular targets. Moreover, Caps does not mediate homophilic interactions
and regulates PN dendrite targeting independent of pre-synaptic ORNs. The closely related protein
Tartan plays a partially redundant function with Capricious. These LRR proteins are likely part of
a combinatorial cell-surface code that instructs discrete olfactory map formation.
Spatial representation of sensory stimuli in the brain is a fundamental organizational
principle that facilitates the processing and integration of sensory information1. In the visual
and auditory systems, neurons connect nearby spatial/frequency inputs to nearby target
regions in the brain, thereby forming a spatially continuous neural map. In contrast, the
olfactory system utilizes discrete channels to detect olfactory information, with each channel
consisting of a group of olfactory receptor neurons (ORNs) that express a specific odorant
receptor. ORNs expressing the same odorant receptor converge their axons to an
anatomically discrete glomerular unit in the insect antennal lobe or vertebrate olfactory bulb,
the first olfactory processing center in the brain. Within each glomerulus, a single class of
ORN axons functionally synapses with the dendrites of a single class of second-order
olfactory neurons: projection neurons (PNs) in insects or mitral cells in vertebrates. Thus,
from insects to mammals, olfactory input and output are spatially organized into distinct
channels via glomeruli, forming a discrete neural map1. Studies of vertebrate visual map
formation have supported a crucial role for continuous gradients of guidance molecules in
instructing the formation of a continuous neural map during development. However, less is
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known about the mechanisms by which a discrete map, exemplified by the olfactory system,
is precisely constructed1,2.
The Drosophila antennal lobe consists of ∼50 glomeruli, which can be uniquely identified
by their stereotypical size, shape and relative position3. Most PNs project their dendrites to a
single glomerulus and synapse with the axons of a single ORN class. The dendrite targeting
of PNs to a specific glomerulus is specified by their lineage and birth order4. Importantly,
the initial targeting of PN dendrites precedes the arrival of pioneering ORN axons5,
suggesting that the coarse glomerular map arises independently of ORN input. The
Drosophila olfactory system thus provides an attractive model system to study mechanisms
of PN dendrite and ORN axon targeting in the context of discrete map formation.
PN dendrite targeting is presumably achieved by differential expression of cell surface
receptors in different classes of PNs such that they can respond differently to a common
environment. Although combinatorial expression of intrinsic transcription factors in PNs has
been shown to regulate PN dendrite targeting6-8, little is known about instructive cell
surface receptors during this process. The transmembrane proteins Dscam and N-Cadherin
play important roles in elaboration and refinement of PN dendrites, respectively9,10, but they
are expressed in and required for all PN classes equally. Differential expression of
transmembrane Semaphorin-1a regulates coarse dendrite targeting along the dorsolateral to
ventromedial axis during the initial formation of the antennal lobe11. However, no cell
surface molecules have been shown to instruct different classes of PN dendrites to select
discrete glomerular targets in a 3-dimensional neural map.
Here we report that the leucine-rich repeat transmembrane protein Capricious (Caps) is
differentially expressed in different classes of PNs and cell-autonomously instructs
glomerulus-specific targeting of PN dendrites. Further analysis suggests that Caps-mediated
local dendrite targeting is independent of presynaptic ORNs, and does not act
homophilically. We propose that Caps mediates interactions among PN dendrites, leading to
a mosaic segregation of Caps-positive and negative PNs to discrete glomerular targets.
Results
Caps is differentially expressed in different PN classes
To identify instructive cell-surface molecules for PN dendrite targeting, we utilized a
recently established database that contains 976 transmembrane and secreted molecules with
potential roles in cell-cell recognition12. 462 transgenic lines with a UAS insertion in the 5′
end of these genes were collected that could potentially drive expression of 410 of these 976
genes, covering ∼40% of the repertoire of the potential cell recognition molecules12. We
expressed each line in a small subset of PNs using Mz19-Gal45. We identified
P{GS6}10839 in the 5′ end of capricious (caps) as showing a strong PN dendrite
mistargeting phenotype.
caps encodes a transmembrane protein with 14 leucine-rich repeats in its extracellular
domain13. Previous studies have shown that caps is involved in regulating cell-cell
interactions in a variety of developmental processes, including boundary formation in wing
and leg discs14,15, organization of the morphogenetic furrow and ommatidial spacing16, and
formation of branch interconnections in tracheal development17. In the nervous system, caps
has been shown to regulate the axon targeting of motor neurons to specific subsets of
muscles12,13 and axon targeting of R8 photoreceptor neurons to the proper layer in the
medulla18.
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Staining with polyclonal antibodies against Caps shows that Caps protein is present in the
developing antennal lobe (Fig. 1a-f; Fig. S1). Around 48 hrs after puparium formation
(APF) when individual glomeruli in the antennal lobe are just becoming identifiable,
differential Caps expression is evident with high levels in some glomeruli and low or
undetectable levels in others (Fig. 1b and 1e). The distinct expression levels of Caps do not
arise from a differential density of neurites, since the density of neurites is rather uniform
between different glomeruli as shown by staining of nc82, a pre-synaptic marker19 (Fig. 1a
and 1d). The Caps staining is eliminated in a loss-of-function caps mutant (Fig. 1h),
indicating that the antibody is specific to endogenous Caps protein. Furthermore, the
expression of UAS-mCD8GFP driven by the enhancer trap caps-Gal4 recapitulates the
glomerular-specific anti-Caps staining pattern (Fig. 1c and 1f, compared with Fig. 1b and
1e), suggesting that caps-Gal4 is a faithful reporter of endogenous Caps expression.
At 48 hrs APF, the antennal lobe consists of dendrites from PNs and axons from ORNs. To
determine the contribution to caps expression by PN dendrites, we generated a PN-specific
flipase line GH146-Flp. Similar to the GH146-Gal4 expression pattern, GH146-Flp is
expressed in the majority of PNs; these PNs innervate 40 out of the 46 glomeruli scored
(Fig. S2a). Therefore, we used a Flp-out GFP reporter UAS>stop>mCD8GFP to determine
the intersection of GH146-Flp and caps-Gal4, and thus Caps expression in PNs (Fig. S2b).
Interestingly, caps-Gal4 is selectively expressed in a subset of PNs innervating 23 out of 40
GH146-positive glomeruli (Fig. 1i-l, Fig. S2b). Glomerular targets of Caps-positive and
Caps-negative PNs do not segregate into broad domains, and appear intercalated (Fig. 1l).
Loss of caps causes mistargeting in Caps-positive PNs
The differential expression of Caps in different glomeruli raised the possibility that Caps
instructs targeting of PN dendrites to specific glomeruli according to Caps expression
patterns. This hypothesis predicts that loss of Caps in Caps-positive PNs should cause their
dendrites to mistarget to glomeruli normally innervated by Caps-negative PNs, whereas it
may not affect the dendrite targeting of Caps-negative PNs. We first tested this prediction by
performing loss-of-function MARCM analyses using the null allele capsc28fs for the lateral
neuroblast clone containing 12 classes of PNs, 9 of which are Caps-positive. Loss of caps in
the lateral neuroblast clones results in two types of dendrite targeting defects: loss of
innervation in glomeruli that are normally targets of lateral PNs, and gain of innervation in
glomeruli that are normally not the targets of lateral PNs (Fig. 2a-c). In accordance with our
prediction, quantitative analysis of dendrite distribution in caps mutants shows that all the
glomeruli that exhibit loss of innervation are targets of Caps-positive PNs, whereas the
ectopically innervated glomeruli are mostly normal targets of Caps-negative PNs (Fig. 2d).
This bias of mistargeting towards normal Caps-negative PN targets is highly significant (X2,
p<0.001; Fig. S3a). Notably, loss of caps in Caps-positive PNs does not cause a random
mistargeting of dendrites to all Caps-negative targets but a preferential mistargeting to
specific ectopic targets (Fig. 2d).
The analysis of 12 PN classes in neuroblast clones suggests that caps is required in PNs for
proper dendrite targeting. However, it is difficult to determine exactly which classes of PNs
contribute to the ectopic innervations and whether the loss of innervation is caused by
mistargeting rather than gross defects in dendrite arborization. In addition, it is unclear
whether the phenotype is caused by a cell-autonomous requirement for caps. To address
these questions, we performed MARCM analysis of specific PN classes, including single
cell clones. Using GH146-Gal4 and MZ19-Gal4, along with additional information of
neuroblast lineage, heat shock window, and axon branching pattern, we sampled four Caps-
negative (DL1, DA1, DC3, and VA1d) and four Caps-positive (VC1, VC2, VA4, and DM1)
PN classes innervating different regions in the antennal lobe (see Methods).
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Consistent with our prediction, the four Caps-negative PN classes (DL1, DA1, DC3, and
VA1d) do not exhibit detectable dendrite targeting defects (Fig. 3, a-c and h-j). However,
loss of caps in four Caps-positive PN classes (VC1, VC2, VA4, and DM1) results in
innervation of additional ectopic glomeruli normally targeted by Caps-negative PNs (Fig. 3,
d-g, k-n). All caps−/− VC1 PNs exhibit strong ectopic innervation, and 92% of this ectopic
innervation occurs in the DA2, DC2, VM7, DC1 and VM5 glomeruli, all of which are
normally innervated by Caps-negative PNs (Fig. 3s-t). Similarly, loss of caps in the Caps-
positive VC2, VA4 and DM1 PNs results in strong ectopic innervation of the VM7, DA2
and VM5 glomeruli, all of which are normally innervated by Caps-negative PNs (Fig. 3u-v).
In both cases, the bias of mistargeting towards normal caps-negative PN targets is highly
significant (X2, p<0.01; Fig. S3b, c). Therefore, the loss-of-function analysis in both
neuroblast and single cell clones suggests that Caps instructs the segregation of Caps-
positive and negative PN dendrites to different glomeruli. In the absence of Caps, Caps-
positive PNs retain part of their dendrites in their normal glomeruli, but mistarget part of
their dendrites preferentially into glomeruli that are normal targets of Caps-negative PNs.
We further noticed that the ectopic glomeruli mistargeted by caps−/− PNs tend to be in close
proximity to their normal glomerular targets (e.g. Fig. 3w for VC1), suggesting that Caps
regulates local dendrite targeting.
To test the cell-autonomy of Caps function, we used MARCM to express a UAS-caps
transgene only in single cells that are homozygous mutant for caps and labeled by mCD8-
GFP. This results in a rescue of the dendrite mistargeting phenotype of all four Caps-
positive PNs (Fig. 3o-r, s, u). Since the GH146-Gal4 used for rescue is expressed only in
postmitotic PNs8, the rescue experiment demonstrates that Caps is cell-autonomously
required in postmitotic neurons for the dendrite targeting of these Caps-positive PNs.
In contrast to dendrite mistargeting, lateral horn axon terminal arborization patterns of caps
mutant PNs still follow their class-specificity previously described20-22 (Fig. S4, see
Methods). This suggests that caps regulates targeting of dendrites as opposed to general fate
determination of PNs, and that dendrite targeting and axon terminal arborization are
separable processes.
Misexpression causes mistargeting in Caps-negative PNs
We have shown that loss of Caps in Caps-positive PNs causes dendrite mistargeting
preferentially to glomerular targets of Caps-negative PNs. Next, we tested whether ectopic
expression of Caps in Caps-negative PNs would cause dendrite mistargeting, and whether
such mistargeting would be preferential to glomeruli that are normally innervated by Caps-
positive PNs. We found that MARCM overexpression of Caps in PN neuroblast clones
caused severe mistargeting, resulting in a deformation of the entire antennal lobe structure
(Fig. 4a-d). Next, we misexpressed Caps using Mz19-Gal4 in 3 classes of PNs, DA1, VA1d
and DC3, which are all Caps-negative and send their dendrites to 3 adjacent glomeruli (Fig.
4e-f). Caps misexpression by Mz19-Gal4 shows a mistargeting of dendrites to nearby
VA1lm (81%) and VA4 (31%), both of which are targets of Caps-positive PNs (Fig. 4f,
arrowheads).
We further misexpressed Caps in a single DL1 PN, which normally neither expresses Caps
(Fig. 1l) nor requires Caps for targeting (Fig. 3h). Caps misexpression produces partial loss
of innervation of the DL1 glomerulus and ectopic innervation of a selective subset of other
glomeruli (Fig. 4g-i); these ectopic glomerular targets are normally innervated by Caps-
positive PNs except DP1l whose Caps expression status is undetermined (Fig. 4j). This bias
of mistargeting towards normal caps-positive PN targets is highly significant (X2, p<0.001;
Fig. S3d), supporting the hypothesis that Caps instructs PN dendrite targeting by segregating
Caps-positive and negative PNs. Notably, over 2/3 of the mistargeting events occur at
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glomeruli near DL1 (DL2d, DL2v, VL2a and VL2p) (Fig. 4k), suggesting that mistargeting
is preferentially local. We also noticed that mistargeted dendrites avoid two glomeruli DL4
and DL5, which are adjacent to DL1 and innervated by Caps-positive PNs (Fig. 4k),
suggesting that mistargeting is not random among local ectopic targets (see Discussion).
Caps misexpression in single DL1 PNs does not affect PN axon targeting in the lateral horn
(Fig. S4c), further confirming that caps specifically regulates the specificity of dendrite
targeting as opposed to the general determination of cell fate.
caps is not required for ORN axon targeting
The expression pattern, loss- and gain-of-function data presented so far demonstrate that
Caps instructs targeting of PN dendrites by segregating Caps-positive and negative PNs to
discrete glomerular targets. We next explored the cellular mechanisms by which Caps
functions to regulate dendrite targeting. Caps has been proposed to determine axon-target
connectivity by regulating the interaction between photoreceptor or motor axons and their
postsynaptic targets13,18. This model is further supported by a recent observation that Caps
appears to mediate direct interaction between postsynaptic filopodia of muscles and
presynaptic growth cones23.
PNs send their dendrites to the developing antennal lobe prior to the arrival of pioneering
ORN axons5. The dendrites subsequently elaborate and refine their processes while ORNs
extend their axons into the antennal lobe9, 10. The glomerular positionings of dendrites and
axons eventually require pre- and postsynaptic interactions, to achieve the proper matching
specificity between PNs and ORNs9. If Caps has an analogous function in the olfactory
system as in motor neurons and photoreceptors, it might mediate interactions between ORN
axons and PN dendrites. However, the following experiments strongly argue against this
model.
To determine whether caps is also expressed in presynaptic ORNs, we examined the
expression intersection between caps-Gal4 and ey-Flp. ey-Flp is expressed in precursors of
ORNs but not in central neurons including PNs24, thereby allowing us to specifically
visualize caps-Gal4 expression in ORNs using a Flp-out reporter. We found that caps-Gal4
is expressed in a subset of ORNs selectively innervating 28 out of 46 glomeruli (Fig. 5a-d,
Fig. S2c). However, glomeruli innervated by Caps-expressing PNs and ORNs exhibit only
partial overlap (Fig. 5e, Fig. S2c), and the correlation between Caps expression in PNs and
ORNs is not statistically significant (X2, p>0.3).
To test whether caps is required in ORNs for their axon targeting, we removed caps from
about half of ORNs using the ey-Flp MARCM strategy24 and analyzed targeting of 9
different ORN classes using Or-Gal4 or AM29-Gal4 lines to label specific classes of ORN
axons. These 9 classes of ORN-PN pairs sample 4 pairs of Caps-positive ORNs and Caps-
positive PNs (Or22a - DM2, Or47a - DM3, Or47b - VA1lm, AM29 - DM6), 4 pairs of Caps-
positive ORNs and Caps-negative PNs, (Or46a - VA7l, Or59c - VM7, Or67b - VA3, Or88a
- VA1d) and 1 pair of Caps-negative ORNs and Caps-positive PNs (AM29 - DL4). None of
these 9 ORN classes exhibit any obvious axon targeting defects (Fig. 5f-i; data not shown),
indicating that caps is not cell-autonomously required in ORNs for their proper axon
targeting.
In addition, when glomerular position of PN dendrites is shifted as a result of loss of caps in
ventral VA1lm PNs, the axons of presynaptic Or47b ORNs shift accordingly without
compromising the matching between ORN axons and PN dendrites (Fig. S5). Thus, loss of
Caps in PNs does not appear to disrupt the proper targeting of ORN axons, at least for the
specific ORN-PN pair we tested.
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Caps-mediated PN dendrite targeting is independent of ORNs
Even though Caps is not required for ORN axon targeting, Caps-dependent PN dendrite
targeting could in principle still depend on the interaction with cues from ORNs. Two lines
of evidence already argue against the possibility that Caps itself provides the putative ORN
derived cue. First, there is only partial overlap between Caps expression pattern in PNs and
ORNs (Fig. 5e, Figure S2). Second, both loss of innervation and ectopic innervation of PN
dendrites occur in glomerular targets of both Caps-positive and Caps-negative ORNs with
no obvious preference (Figure S3a-d). These observations argue against a specific
hypothesis that PN dendrite targeting is dependent on homophilic interactions of Caps
between PN dendrites and ORN axons. Below we provide two lines of evidence further
suggesting that Caps-mediated PN dendrite targeting is independent of ORN axons.
We have previously shown that PNs start to elaborate dendrites shortly after puparium
formation and that PN dendrites localize to their initial stereotypical target region of the
developing antennal lobe before pioneering ORN axons arrive at 18 hrs APF5. Therefore, an
examination of dendrites at 16 hrs APF will allow us to examine the ORN-independent
phase of early PN dendrite targeting. Developmental time course analysis of Caps
expression in the antennal lobe indicates that at 12-16 hrs APF, the developing antennal lobe
is already stained positive for both Caps-specific antibody and caps-Gal4 expression (Fig.
S1), confirming that Caps is expressed in developing PN dendrites. At 16 hrs APF, all wild-
type DL1 PN dendrites localize to the dorsal-lateral corner of the developing antennal lobe
(Fig. 6a); however, Caps misexpression in DL1 already causes dendrites to extend across the
midline of the dorsomedial-ventrolateral axis of the antennal lobe in ∼40% of the samples
(Fig. 6b), arguing against the possibility that Caps mediates interactions between PN
dendrites and ORN axons, at least for PN initial targeting. The medial mistargeting
phenotype persists at 48 hrs APF (Fig. 6d, compared with Fig. 6c), and the penetrance of
mistargeting is comparable among different developmental stages (Fig. 6e), suggesting that
adult defects are likely caused by defects in early PN dendrite targeting.
To further test whether ORN axons are involved in Caps-instructed PN dendrite targeting at
a later developmental stage, we compared Caps misexpression phenotypes in an otherwise
normal or ORN-ablated background. If Caps instructs PN dendrite targeting by mediating
the interactions between ORN axons and PN dendrites, we expect that ORN ablation would
suppress the mistargeting phenotypes of PN dendrites caused by PN misexpression of Caps.
To ablate all ORNs during early development, we used Pebbled-Gal4 and ey-Flp to express
the flip-out toxin UAS>stop>RicinA. Pebbled-Gal4 and ey-Flp are expressed in all ORNs
during early development24 and therefore this strategy ablates almost all ORNs before their
axons enter the developing antennal lobe (Fig. S6). ey-Flp is not expressed in PNs or their
progenitors, allowing us to simultaneously use a PN-specific Mz19-Gal4 line to assess PN
dendrite development in ORN ablated animals.
Mz19-Gal4 labels 3 PN classes innervating 3 adjacent glomeruli, DA1, VA1d and DC3,
located in the dorsolateral region of the antennal lobe (Fig. 6f). When ORNs are ablated
during development, the dendrites of these 3 PN classes still converge to discrete regions
and remain adjacent to each other, although they are located in the ventrolateral region due
to a shift of the antennal lobe orientation in the absence of ORN axons (Fig. 6h). The
ablation experiment suggests that PNs retain their intrinsic ability to converge their dendrites
to specific glomerular regions at both early and later developmental stages without the
contribution of ORN axons. Caps misexpression by Mz19-Gal4 results in mistargeting of
PN dendrites to VA1lm and VA4 and the dendrites were frequently segregated to non-
adjacent regions in the antennal lobe as a consequence of this mistargeting (Fig. 6g).
Interestingly, this dendrite segregation also occurred when Caps is misexpressed by Mz19-
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Gal4 after ablating all ORNs (Fig. 6i), and the penetrance is comparable to Caps
misexpression without ORN ablation (Fig. 6j).
Taken together, these data strongly suggest that Caps instructs PN dendrite targeting
independently of ORN axons throughout development. Besides ORNs, PNs are the only cell
type that can provide class-specific positional cues. Given the mosaic distribution of Caps-
positive and negative glomeruli, we suggest that Caps regulates PN dendrite targeting
through PN-PN interactions—as opposed to responding to a global cue—leading to a
segregation of Caps-positive and negative PNs (see Discussion).
Caps does not mediates homophilic interactions
Caps has been proposed to act as a homophilic recognition molecule based on its ability to
promote S2 cell aggregation, although this can only be seen when the expression level is
very high13,14,18 (A. Nose, personal communication). Here, we used a genetic approach to
functionally test whether Caps mediates homophilic interactions in vivo during PN dendrite
targeting. We have shown that Caps misexpression in a single Caps-negative DL1 PN
results in a preferential mistargeting (Fig. 4h-i and 7b). If homophilic interactions among
Caps-expressing cells underlie this misexpression phenotype, we would expect that
eliminating endogenous Caps expression in the entire animal would suppress this phenotype.
The caps homozygous mutants die primarily as embryos, but a few escapers (<0.1%) survive
until adulthood. DL1 PN dendrites still target properly to the DL1 glomerulus in these caps
homozygous mutant escapers (Fig. 7a). However, ectopic expression of Caps in a single
DL1 PN in these caps mutant escapers still caused mistargeting of DL1 dendrites to ectopic
glomeruli in the antennal lobe (Fig. 7c). Quantification shows that Caps misexpression in
single DL1 PN caused a similar degree of mistargeting in a whole animal caps−/−
background as in the wild type (Fig. 7d), indicating that Caps-dependent dendrite targeting
does not use Caps in other cells as a cue, at least in the gain-of-function context. Overall,
these data suggest that Caps uses a heterophilic ligand to instruct dendrite targeting.
Partially redundant function of Caps and Trn
Caps shares 67% sequence identity in its extracellular domain with another leucine-rich
repeat transmembrane protein Tartan (Trn)13,25, the closely related paralog of Caps. trn and
caps have redundant functions in regulating boundary formation in wing imaginal dics14,26,
leg segmentation15, and the architecture of the morphogenetic furrow and ommatidial
spacing16. In the nervous system, trn and caps also have redundant functions in regulating
motor axon targeting12,23. Indeed, Trn overexpression also results in dendrite mistargeting
phenotypes in neuroblast and DL1 single PN clones (Fig. S7a-f). Moreover, expression of an
enhancer trap trn-lacZ together with caps-Gal4, GH146-Flp and UAS>stop>mCD8GFP
suggests that trn is expressed in PNs and partially overlaps with caps expression (Fig. S7g).
To test the requirement of trn in PN dendrite targeting, and its potential redundant function
with Caps, we performed loss-of-function studies of trn single and trn caps double mutants
analogous to the caps studies described above (Fig. 8). We found that loss of trn in the
lateral neuroblast clone resulted only in ectopic innervation, but two independent trn caps
double mutant pairs showed a significantly higher percentage of combined loss-of-
innervation and ectopic innervation compared with either of the single mutants (Fig. 8a). A
glomerulus is usually innervated by multiple PNs so that ectopic innervation reflects a
partial mistargeting of these PNs whereas loss-of-innervation indicates all these PNs
completely mistarget away from the normal region. The loss-of-innervation of VA7m, VC1
and VC2 were not observed in either caps (Fig. 2d) or trn single mutants but occurred
frequently in trn caps double mutants (Fig. 8c), indicating that trn caps double mutants
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exhibit more severe mistargeting phenotypes. Furthermore, single cell loss-of-function
analysis of VC1 and VC2/VA4/DM1 PNs consistently exhibited more severe mistargeting
phenotypes for double mutants than either of the single mutants (Fig. 8b). For example, caps
single mutant VC1 PNs always retain a part of their dendrites in the VC1 glomerulus (Fig.
8b, e); however, a large percentage of trn caps double mutant VC1 PNs no longer innervate
VC1 at all (Fig. 8b, g, h), consistent with the strong loss-of-innervation of VC1 observed in
lateral neuroblast clones of trn caps double mutants. However, similar to the caps single
mutant, neither trn single nor trn caps double mutants exhibit any detectable targeting
defects in the axons of 9 different ORN classes tested for caps single mutants (data not
shown), suggesting that Trn and Caps are dispensable for ORN axon targeting.
Given that Caps and Trn have high sequence similarity, similar overexpression phenotypes,
overlapping expression patterns, and enhancement of PN dendrite mistargeting in double
mutants compared with either of the single mutants alone, we conclude that Caps and Trn
play partially redundant function in PN dendrite targeting.
Discussion
Discrete cell surface codes in a discrete neural map
Graded expression of guidance molecules is widely used in patterning continuous,
topographic representation of sensory inputs. A classic example is graded Ephrin/Eph
signaling in regulating retinotopic projections in vertebrates1,27. Graded molecules may also
be used in the initial coarse patterning of discrete olfactory maps in flies and mice11,28, but
selective targeting to discrete glomerular units requires additional mechanisms. Here, we
showed that the LRR transmembrane protein Caps is expressed in a subset of PNs whose
dendrites target to a subset of glomeruli intermingled with other glomeruli targeted by Caps-
negative PNs. Loss of caps selectively affects targeting of Caps-positive PNs, causing them
to partially but preferentially mistarget to glomeruli normally innervated by Caps-negative
PNs. Conversely, misexpression of Caps in Caps-negative PNs causes them to selectively
target dendrites to glomeruli that are normal targets of Caps-positive PNs. These data
demonstrate that Caps instructs the segregation of Caps-positive and negative PN dendrites
to discrete glomerular targets in the Drosophila antennal lobe.
How does Caps-mediated targeting act together with molecular gradients used for
establishing the coarse dendrite map? A general conceptual problem of making a discrete
map based on gradient cues is that nearby discrete glomerular units have to be distinguished
with a minimal difference in gradient cues. One potential solution would be to set a second
type of cell surface molecules that form a spatially intercalated expression pattern with a
tight correlation with each discrete class of neurons. Indeed, recent studies in mouse ORN
axon targeting suggested a hierarchical model in which molecular gradients help coarse
targeting of axons, followed by local refinement mediated by activity-dependent expression
of cell recognition molecules1,2. Neuropilin-1 and Semaphorin-3A are expressed in broad
domains in olfactory bulb and disruption of Semaphorin-3A causes global axon
mistargeting29-33. However, other cell surface molecules, including Ephrin-A2/A5 and
EphA5, as well as immunoglobulin superfamily proteins Kirrel-2, Kirrel-3, and BIG-2, are
differentially expressed in a mosaic pattern and likely regulate local axon targeting through
axon-axon interactions among ORNs34-36.
Drosophila PN dendrite targeting appears to utilize a conceptually similar strategy even
though details may differ regarding types of molecules, cells (ORNs vs. PNs), neuronal
processes (axons vs. dendrites), and dependence on activity; this hierarchical regulation may
be a general strategy for discrete map formation. Specifically, we propose that molecular
gradients such as Semaphorin-1a may set up a coarse map for PN dendrites. This is followed
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by Caps-dependent local dendrite targeting to discrete glomeruli. In support of this notion,
loss of semaphorin-1a causes a directional shift of dendrites11, whereas loss of caps cause a
specific mistargeting to local ectopic targets.
Both loss-of-function and misexpression analyses indicate that the mistargeted dendrites are
restricted to only a subset of ectopic glomeruli following the Caps code. For example, Caps-
misexpressing DL1 PNs mistarget to the DL2v and DL2d glomeruli but avoid DL4 and DL5
glomeruli, even though they are all in the vicinity of DL1 and are normal targets of Caps-
positive PNs. Similarly, caps loss-of-function in VC1 PNs causes dendrites to mistarget to
VM7, DC2, DC1, VM5 but avoid VL1, DP1m and DC3, even though they are all in the
vicinity of VC1 and are normal targets of Caps-negative PNs. These observations suggest
that additional molecules must work together with Caps to distinguish targeting specificity
among different Caps-positive PNs or among different Caps-negative PNs. Since these
additional molecules are still intact in PNs with an altered Caps code, their actions might
explain the mistargeting specificity. Thus, Caps likely acts in parallel with additional
molecules to specify dendrite targeting of the 50 PN classes into areas that eventually
develop into 50 glomeruli.
Cellular and molecular mechanisms
The matching expression of Caps in motor neurons and their target muscles12,13, as well as
in R8 photoreceptor axons and their target layers18, suggest that Caps functions in synaptic
matching through interactions between pre- and post-synaptic partners. During the assembly
of the olfactory system, 50 classes of ORN axons need to match with 50 classes of PNs.
However our data strongly argue against the possibility that the PN dendrite targeting defect
is caused by a predominant role of Caps in mediating synaptic matching between ORN
axons and PN dendrites. First, caps is required for targeting of PN dendrites but not ORN
axons. This cannot be caused by the redundancy with a close paralog Trn, as trn caps double
mutants enhance caps phenotypes in PN dendrite targeting, but still exhibit no phenotypes in
ORNs. Second, expression patterns of Caps in PNs and ORNs do not match with regard to
their glomerular targets. Third, Caps-mediated PN dendrite targeting is independent of
ORNs. Fourth, Caps misexpression phenotype is not affected by the loss of Caps in all other
cells, suggesting that it interacts with a heterophilic ligand for PN dendrite targeting.
The use of a heterophilic ligand is consistent with studies of Caps in boundary formation of
the wing imaginal disc14,26. Given the mosaic distribution of Caps-positive and negative
glomeruli, as well as the analogy with the axon-axon interactions in refining local targeting
of mouse ORN axons, we propose that the heterophilic Caps ligand is most likely derived
from other PNs, and that the interactions between Caps and its ligand mediate PN-PN
interactions to segregate Caps-positive and negative PNs to specific glomeruli.
How do Caps and its heterophilic ligand segregate Caps-positive and negative PNs via PN-
PN interactions? The simplest hypothesis consistent with our data is that a repulsive ligand
is expressed in Caps-negative PNs, forming a mosaic pattern complementary to Caps. Caps
and its ligand mediate repulsive interactions among PN dendrites to segregate Caps-positive
and negative PNs. When Caps is lost in a Caps-positive PN, its dendrites innervate ectopic
glomeruli that are preferentially targets of Caps-negative PNs because of a loss of repulsion
from Caps-negative PN dendrites; additional molecules that normally instruct Caps-positive
PN dendrites to select a specific Caps-positive glomeruli are still intact, thereby preventing
caps mutant PNs from invading other Caps-positive glomeruli. When Caps is misexpressed
in a Caps-negative PNs, the repulsive ligand would force dendrites to mistarget to
glomerular targets of Caps-positive PNs. Future identification of the Caps ligand will be
essential to test this hypothesis, and will shed further light on the mechanisms of discrete
olfactory map formation.
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Methods
Fly stocks
GH146-Gal437 and Mz19-Gal45 are used to label PNs. Or-Gal4 lines (Or22a-Gal4, Or46a-
Gal4, Or47a-Gal4, Or47b-Gal4, Or59c-Gal4, Or67b-Gal4, Or88a-Gal4)24,38-41 and AM29-
Gal442 are used to label ORNs. The enhancer trap line caps-Gal4 (NP3294)18 is used to
visualize Caps-expressing neurons and trn-lacZ25 is used to visualize Trn-expressing cells.
P{GS6}10839 (caps) and P{GS6}10885 (trn) were generated by Drosophila Gene Search
Project (Metropolitan University, Tokyo)43. The single and double null mutant alleles of
caps and trn used are capsc28fs FRT2A15,18, trn28.4 FRT2A15,25, trnΔ17 capsc28fs FRT2A15,
and trn28.4 capsΔ1 FRT80B16 as well as a small caps deficiency allele Df(3L)Ex6118.
capsc28fs contains a 7-base pair deletion, which results in a frame shift after the first 28
amino acids15,18. trn28.4 carries a small deletion of trn gene generated by P-element
excision25. trnΔ17 capsc28fs was generated based on the null allele capsc28fs and carries an
additional deletion covering the entire trn coding sequence15. trn28.4 capsΔ1 was generated
based on the null allele trn28.4, and carries an additional deletion covering the entire caps
coding sequence16. UAS-caps transgene13 inserted on the 3rd chromosome is used for
rescue and misexpression experiments. Flies used in the overexpression screen were
previously described12.
Clonal analysis
The MARCM method was applied as described previously44,45. Briefly, caps and/or trn
alleles were placed transheterozygous to Gal80 on the FRT chromosome arm15,18. Flipase
activity causes mitotic recombination of the FRT chromosome arm such that one of the
daughter cells become homozygous for caps or trn and simultaneously loses Gal80. This cell
(and its progeny) can therefore be labeled by the Gal4/UAS system.
For ORN analysis, eyFlp was utilized to induce clones in nearly half of the ORNs and Or-
specific Gal4 lines were used to label these clones.
For PN analysis, clones were generated by hsFlp and labeled by GH146-Gal4 or Mz19-
Gal4. For generating neuroblast clones, flies were heat-shocked between 24–36 hrs after egg
laying for 1 hr at 37 °C. For generating class-specific clones, flies were heat-shocked during
a unique time window after egg laying (AEL) for 1 hr at 37 °C and the clone identities were
determined by a combined information of Gal4 lines used, heat shock window, neuroblast
lineage, and axon branching pattern. Four Caps-negative (DL1, DA1, DC3, and VA1d) and
four Caps-positive (VC1, VC2, VA4 and DM1) PN classes are investigated here. Mz19-
Gal4 labels DC3 and VA1d from the anterodorsal neuroblast and DA1 from the lateral
neuroblast5. We used MZ19-Gal4 to analyze dendrite targeting of DC3/VA1d and DA1 by
generating neuroblast clones at 24–36 hrs AEL. The other five classes were analyzed as
single cell clones using GH146-Gal4. To analyze DL1 PNs, we heat-shocked flies between
24–36 hrs AEL—100% anterodorsal PN single cell clones generated at this time are DL14.
To analyze the four Caps-positive PNs in the lateral lineage, we identified a time window of
clone induction (36-48 hrs AEL) in which all GH146-Gal4-positive single cell PN clones
generated from the lateral neuroblast are caps-positive and project their dendrites to VA4,
DM1, VC1 or VC2 glomerulus in wild-type controls (Fig. 3d-g). The axon branching pattern
of VC1 in the lateral horn is uniquely identifiable among the four groups and is unchanged
in caps mutants (Fig. S4). (We performed a blind test of mixing axon patterns of single cell
MARCM clones of 4 PN classes each with 3 genotypes—control, mutant and rescue, and all
VC1 PNs were identified in the blind test with 100% accuracy; the mutant VC1 samples
were additionally validated by their partial dendrite innervation of VC1 in additional to
ectopic glomeruli.) These criteria allowed us to identify VC1 PNs unequivocally. The other
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three Caps-positive PN classes (VC2, VA4 and DM1) also have characteristic lateral horn
axon branching patterns that are largely unchanged in mutants. However their axon
branching patterns are more similar to each other and were not 100% identified in our blind
test. Therefore we analyzed dendrite mistargeting of these three classes together (Fig. 3u-v).
We assigned a class to each representative image in Fig. 3l-n based on their partial
innervation of VC2, VA4 or DM1. Animals were raised at 25 °C after heat-shock and
dissected 5–7 days after eclosion.
For analyzing DL1 single cell misexpression during development, flies were raised at 29 °C
after heat-shock to increase expression level and overcome Gal80 perdurance. Animals were
dissected at 12 hrs APF and 36 hrs APF at 29 °C, which are equivalent to 16 hrs APF and 48
hrs APF at 25 °C, respectively.
To determine whether the preference of mistargeting events that occur in glomerular targets
of Caps-positive or negative PNs (or ORNs) is statistically significant, each experiment was
tested by X2 based on the null hypothesis that mistargeting events occur randomly in Caps-
positive and negative glomeruli. p values were shown for each experiment and used to
accept or reject the null hypothesis.
Genotypes for PN MARCM analysis: hsFlp122 UAS-mCD8GFP; GH146-Gal4 UAS-
mCD8GFP; caps (and/or trn) FRT2A (or FRT80B) / G80 FRT2A (or FRT80B). For ORN
analysis: eyFlp UAS-mCD8GFP; Or-Gal4 UAS-mCD8GFP; caps (and/or trn) FRT2A/G80
FRT2A.
New transgenes
GH146-Flp cloning: The p[GAL4, w+]GH146 enhancer trap is inserted in the 5′ upstream
region of the oaz gene (CG17390). The cloned GH146 genomic enhancer is a 12.6 kB
fragment that includes all genomic DNA between oaz and the upstream gene CG17389 as
well as all oaz introns. The GAL4 coding region from pBAC-3xPDsRed-GH146-GAL446
was replaced with GAL80 to generate pBAC-3xPDsRed-GH146-GAL80 (Potter and Luo,
unpublished). Site-directed mutagenesis of pBAC-3xPDsRed-GH146-GAL80 was used to
introduce FseI and AvrII restriction sites flanking the GAL80 coding region. A linker oligo
was ligated into the FseI/AvrII site to generate pBAC-3xPDsRed-GH146-MCS with
multicloning site FseI-AscI-AvrII. Mammalian optimized FLPase (FLPo; Addgene plasmid
13792)47 was PCR amplified to include FseI/AvrII restriction sites, and cloned into
pBAC-3xPDsRed-GH146-MCS to generate pBAC-3xPDsRed-GH146-FLPo.
UAS-FRT-Stop-FRT-mCD8GFP cloning: The FRT-stop-FRT cassette, with additional
BglII/NotI restriction sites, was PCR amplified from genomic DNA of UAS-FRT-stop-FRT-
shibirets flies48 and cloned into pUAST-mCD8GFP45 to generate pUAST-FRT-stop-FRT-
mCD8GFP. All constructs were sequence verified. Transgenic animals were generated as
previously described49.
Immunochemistry
The procedures for fixation, immunochemistry and imaging were as described previously50.
Primary antibodies are Mouse nc82 (1:30), Rat anti-N-cadherin (1:40), Rat anti-mCD8
(1:100), Chicken anti-GFP (1:300) and Rabbit anti-Caps (1:100)13.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Caps is differentially expressed in the developing antennal lobe
(a-h) The developing antennal lobes at 48 hrs APF stained by antibodies against a synaptic
marker nc82 (a, d and g), Caps (b, e and h) and caps-Gal4-driven mCD8-GFP (c and f).
Caps is differentially expressed in the wild-type developing antennal lobe as shown in a
single anterior (a-c) and posterior section (d-f) from the same triple-labeled brain. (g-h) Caps
staining is absent in capsc28fs/Df(3L)6118 trans-heterozygous mutant antennal lobes.
(i-k) Expression of a Flp-out GFP reporter UAS>stop>mCD8GFP at the intersection of
caps-Gal4 and PN-specific GH146-Flp in the adult antennal lobe. Three single sections in
anterior, central, and posterior regions of the antennal lobe are shown. (Magenta: nc82;
Green: mCD8GFP)
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(l) Schematic representation of the glomerular innervation pattern of caps-Gal4-expressing
PNs across three different sections of the antennal lobe. Three groups of glomeruli are
indicated in the legend to the left. See Fig. S2 for details. Antennal lobes in this and all
subsequent images are shown such that dorsal is up and medial is to the left. Scale bars
represent 10 μm.
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Figure 2. Dendrite targeting phenotypes of caps−/− neuroblast clones
(a and b) Dendrite targeting of neuroblast MARCM clones of wild-type and caps−/− PNs. (a)
Wild-type lateral neuroblast clones stereotypically target dendrites to 12 glomeruli. (b)
caps−/− lateral neuroblast clones exhibit selective dendrite mistargeting: arrowhead indicates
the ectopic innervation of VM7 where wild-type PNs do not innervate; arrow indicates the
loss of innervation of wild-type glomerular target VA4.
(c) Quantification of dendrite targeting defects in lateral neuroblast MARCM clones of
control and caps mutant. The Y-axis represents the percentage of the antennal lobes that
exhibit mistargeting phenotypes. Light-grey color, dark-grey color, and black color represent
the percentages of the antennal lobes: that innervate ectopic glomeruli in addition to the
normal glomerular targets, that only exhibit loss of innervation of the normal glomerular
targets, and that exhibit both defects, respectively. (Control: n=9; caps−/−: n=12.)
(d) Glomerular innervation specificity of lateral neuroblast MARCM clones of control and
caps mutants analyzed in (c). The left 12 columns are the normal glomerular targets of
lateral PNs; green bars: the percentage of antennal lobes in which an individual glomerulus
is innervated; white bars: the percentage of antennal lobes in which a normally innervated
glomerulus is not innervated. The right 34 columns are glomeruli that are normally not
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innervated by lateral PNs; black bars: the percentage of antennal lobes in which an ectopic
glomerulus is innervated. All glomeruli are color-coded at the bottom based on the
expression of Caps in the corresponding PNs as indicated. ND, not determined for Caps
expression (GH146-negative).
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Figure 3. Cell-autonomous requirement of Caps in Caps-positive PNs for dendrite targeting
(a-c, h-j) Normal dendrite targeting of caps−/− MARCM clones in DL1 single cells (h), DA1
neuroblasts (i) and VA1d/DC3 neuroblasts (j), compared with wild-type (a-c). These PNs
are all Caps-negative. n=20 for both wild-type and caps−/−.
(d-g, k-n) Defective dendrite targeting of VC1, VC2, VA4 and DM1 PNs in single-cell
caps−/− clones (k-n) compared with wild-type (d-g). These PNs are all Caps-positive. Their
identities are determined as described in the Methods.
(o-r) Rescue of dendrite targeting of four Caps-positive PNs by expressing a UAS-caps
transgene only in the single-cell clones.
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(s-v) Quantification (s, u) and glomerular innervation specificity (t, v) of dendrite targeting
defects in single-cell clones of control and caps mutant analyzed in (d-g, k-r). VC2, VA4
and DM1 were analyzed together (see Methods). (s, u) Y-axes represent the percentage of
PNs in particular classes that exhibit dendrite mistargeting phenotypes. (t, v) Each black bar
indicates the percentage of antennal lobes in which an ectopic glomerulus is innervated. All
glomeruli are color-coded at the bottom as in Fig. 2d. VC1 and VC2/VA4/DM1 classes are
omitted in t and v, respectively, as they are the ones from which clones were made. (Wild-
type: VC1 n=15, VC2 n=15, VA4 n=15, DM1 n=10; caps−/−: VC1 n=7; VC2/VA4/DM1
n=19; Rescue: VC1 n=6, VC2 n=5, VA4 n=6, DM1 n=4).
(w) Schematic representation of the glomerular innervation pattern of individual caps−/−
VC1 PNs across three different sections of the antennal lobe. Red glomeruli are the ectopic
targets of caps−/− VC1 dendrites.
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Figure 4. Dendrite targeting phenotypes of Caps misexpression in Caps-negative PNs
(a-d) MARCM overexpression of Caps in anterodorsal (b) and lateral (d) neuroblast clones
shows severe mistargeting phenotypes, compared to wild type neuroblast clones (a and c).
(Control: n=9; Caps misexpression: n=10).
(e-f) Caps misexpression in DA1, DC3 and VA1d PNs using Mz19-Gal4 shows strong
mistargeting of dendrites to VA1lm and VA4 (arrowheads), both of which are normally
innervated by Caps-positive PNs. (Control: n=40; Caps misexpression: n=48).
(g-i) Misexpression of Caps in single DL1 PNs using GH146-Gal4 causes mistargeting of
dendrites to ectopic glomeruli (arrowheads in h-i).
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(j) Quantification of glomerular innervation pattern of individual DL1 PNs misexpressing
Caps. Each black bar indicates the percentage of antennal lobes in which an ectopic
glomerulus is innervated. All glomeruli are color-coded at the bottom as in Fig. 2d. (Control:
n=20; Caps misexpression: n=19).
(k) Schematic representation of the glomerular innervation pattern of individual Caps-
misexpressing DL1 PNs across three different sections of the antennal lobe. Red glomeruli:
ectopic targets of DL1 dendrites misexpressing Caps.
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Figure 5. caps is not required in ORNs for their axon targeting
(a-c) Expression of an intersectional reporter UAS>stop>mCD8GFP for caps-Gal4 and ey-
Flp. (ey-Flp is expressed in ORN precursors but not PNs or their precursors). Magenta:
nc82; Green: mCD8GFP.
(d) Schematic representation of the glomerular innervation pattern of caps-Gal4 expressing
ORNs across three different sections of the antennal lobe. Gray glomeruli: targets of caps-
Gal4 positive ORNs; white glomeruli: targets of caps-Gal4 negative ORNs.
(e) Schematic comparison of the innervation pattern of Caps-positive PNs and ORNs. See
also Fig. S2.
(f-i) Axon targeting of ORNs in the antennal lobe is not affected in caps−/− ORNs. Or67b
ORNs innervating VA3 and Or22a ORNs innervating DM2 are shown. In these
experiments, only caps−/− axons of a particular class of ORNs are visualized by the Gal4
lines, whereas all the cells in the central brain, including all PNs, are heterozygous because
ey-Flp restricts recombination in the olfactory system to the peripheral organs.
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Figure 6. Caps-mediated PN dendrite targeting is independent of ORNs
(a-d) Mistargeting of DL1 PN dendrites caused by Caps misexpression is observed at early
developmental time points. Dotted lines bisect the antennal lobe into dorsolateral and
ventromedial parts. Arrowheads in (b) and (d) point to DL1 dendrites that cross the dotted
line and invade the ventromedial part of the antennal lobe.
(e) Quantification of mistargeting across the dorsomedial-ventrolateral midline of the
antennal lobe (dotted lines in a-d) at different developmental stages. Adult: n=12; 16 hrs
APF: n=10; 48 hrs APF: n=5.
(f-j) Caps misexpression by Mz19-Gal4 causes a segregation of dendritic field as a
consequence of dendrite mistargeting to VA1lm and VA4 (arrowheads in g), compared to
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continual dendritic field from control Mz19-Gal4 labeled PNs (f). Caps misexpression by
Mz19-Gal4 in ORN-ablated animals causes dendrite segregation (i) compared with control
Mz19 PNs in ORN-ablated animals which forms a continual field (h). (j) Quantification of
the dendrite segregation phenotypes caused by Mz19-Gal4 misexpression of Caps, with and
without ORN ablation. Caps misexpression without ORN ablation: n=48; Caps
misexpression with ORN ablation: n=18.
Hong et al. Page 25
Nat Neurosci. Author manuscript; available in PMC 2010 June 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 7. Caps does not mediate homophilic interactions for PN dendrite targeting
(a) Normal dendrite targeting of a single DL1 PN in a caps whole animal mutant (capsc28fs/
Df(3L)6118).
(b-c) Dendrite mistargeting of a single DL1 PN misexpressing Caps in an otherwise wild-
type background (b) or an otherwise capsc28fs/Df(3L)6118 mutant background (c).
(d) Quantification of DL1 targeting defects for genotypes in a-c. (DL1 labeling in wild-type
background: n=20; DL1 labeling in trans-heterozygous mutant background: n=20; Caps
misexpression in a otherwise wild-type background: n=8; Caps misexpression in a otherwise
trans-heterozygous mutant background: n=9). Grey bars represent the percentage of partial
mistargeting events in which PN dendrites still partially innervate DL1 and black bars
represent the percentage of full mistargeting events in which no dendrites innervate DL1.
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Figure 8. trn enhances caps phenotypes in PN dendrite targeting
(a) Quantification of dendrite targeting defects in lateral neuroblast MARCM clones of
control, single, and double mutants of caps and trn as indicated. The Y-axis and the colored
bars are represented as described in Fig. 2c. (Wild-type: n=31; capsc28fs FRT2A: n=30;
trn28.4 FRT2A: n=18; trnΔ17 capsc28fs FRT2A: n=17; trn28.4 capsΔ1 FRT80B: n=11)
(b) Quantification of dendrite targeting defects in single-cell MARCM clones of control,
single, and double mutants of caps and trn as indicated. The Y-axis and the bars are
represented as described in Fig. 7d. (For VC1, wild-type: n=20; capsc28fs FRT2A: n=7;
trn28.4 FRT2A: n=5; trnΔ17 capsc28fs FRT2A: n=5; trn28.4 capsΔ1 FRT80B: n=5. For VC2/
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VA4/DM1, wild-type: n=30, capsc28fs FRT2A: n=19, trn28.4 FRT2A: n=13, trnΔ17 capsc28fs
FRT2A: n=16, trn28.4 capsΔ1 FRT80B: n=13).
(c) Glomerular innervation specificity of lateral neuroblast MARCM clones of trn single
mutant and caps, trn double mutants analyzed in (a). The Y-axis and the colored bars are
represented as described in Fig. 2d.
(d-h) Dendrite targeting of single-cell VC1 MARCM clones of control, single, and double
mutants of caps and trn as indicated. Arrowheads indicate the ectopic innervation of DA2
where wild-type VC1 PNs do not innervate.
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